Technical Analysis for MLNT - Melinta Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 5.09 1.19% 0.06
MLNT closed up 1.19 percent on Monday, March 18, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical MLNT trend table...

Date Alert Name Type % Chg
Mar 18 MACD Bullish Signal Line Cross Bullish 0.00%
Mar 18 Calm After Storm Range Contraction 0.00%
Mar 18 Wide Bands Range Expansion 0.00%
Mar 15 Fell Below 20 DMA Bearish 1.19%
Mar 15 Volume Surge Other 1.19%
Mar 15 Wide Bands Range Expansion 1.19%
Mar 14 50 DMA Resistance Bearish -9.75%
Mar 14 Crossed Above 20 DMA Bullish -9.75%
Mar 14 New Uptrend Bullish -9.75%
Mar 14 Pocket Pivot Bullish Swing Setup -9.75%

Older signals for MLNT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Melinta Therapeutics, Inc., formerly Cempra, Inc., is a clinical-stage pharmaceutical company. The Company focuses on developing differentiated antibiotics for the acute care and community settings to meet medical needs in the treatment of bacterial infectious diseases. Its product, solithromycin (CEM-101), which is a macrolide and fluoroketolide, is being developed in oral capsules, intravenous (IV) and suspension formulations for the treatment of community-acquired bacterial pneumonia (CABP). Solithromycin has therapeutic potential and activity to target pathogenic bacteria. It has completed two pivotal Phase III trials for solithromycin to treat CABP, as of December 31, 2016. Its Fusidic acid is an antibiotic and the Company is exploring its use for the long-term oral treatment for refractory bone and joint infections (BJI), including prosthetic joint infections, which are caused by staphylococci, including S. aureus, methicillin-resistant S. aureus and other gram-positive bacteria.
Medical Specialties Pharmaceutical Infectious Diseases Antibiotics Microbiology Healthcare Associated Infections Bacterial Diseases Staphylococcus Aureus Pathogenic Bacteria Community Acquired Bacterial Pneumonia
Is MLNT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 53.0
52 Week Low 3.2
Average Volume 428,073
200-Day Moving Average 17.5618
50-Day Moving Average 5.694
20-Day Moving Average 5.3575
10-Day Moving Average 4.927
Average True Range 0.7692
ADX 34.83
+DI 27.3523
-DI 24.4665
Chandelier Exit (Long, 3 ATRs ) 6.142399999999999
Chandelier Exit (Short, 3 ATRs ) 6.5176
Upper Bollinger Band 6.6013
Lower Bollinger Band 4.1137
Percent B (%b) 0.39
BandWidth 46.432105
MACD Line -0.3452
MACD Signal Line -0.3526
MACD Histogram 0.0074
Fundamentals Value
Market Cap 267.27 Million
Num Shares 52.5 Million
EPS -1.89
Price-to-Earnings (P/E) Ratio -2.69
Price-to-Sales 6.92
Price-to-Book 0.80
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.76
Resistance 3 (R3) 5.70 5.43 5.64
Resistance 2 (R2) 5.43 5.26 5.46 5.61
Resistance 1 (R1) 5.26 5.16 5.35 5.31 5.57
Pivot Point 4.99 4.99 5.03 5.01 4.99
Support 1 (S1) 4.82 4.82 4.90 4.87 4.61
Support 2 (S2) 4.55 4.71 4.57 4.57
Support 3 (S3) 4.37 4.55 4.54
Support 4 (S4) 4.42